Paul Streck

Insider Reports History

Entity
Individual
Location
10 Finderne Avenue, Building 10, Bridgewater, NJ
Signature
/s/ Mary Beth DeLena, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Streck:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PepGen Inc. EVP, Head of R&D Stock Option (Right to Buy) 243K Aug 19, 2024 Direct
ALBIREO PHARMA, INC. Chief Medical Officer Restricted Stock Units 0 Mar 2, 2023 Direct

Insider Reports Filed by Paul Streck

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PEPG PepGen Inc. Aug 19, 2024 2 $0 4 Aug 20, 2024 EVP, Head of R&D
PEPG PepGen Inc. Aug 19, 2024 0 $0 3 Aug 20, 2024 EVP, Head of R&D
ALBO ALBIREO PHARMA, INC. Mar 2, 2023 1 $0 4 Mar 2, 2023 Chief Medical Officer
ALBO ALBIREO PHARMA, INC. Jan 19, 2023 1 $0 4/A Jan 27, 2023 Chief Medical Officer
ALBO ALBIREO PHARMA, INC. Dec 19, 2022 1 $0 4 Dec 21, 2022 Chief Medical Officer
ALBO ALBIREO PHARMA, INC. Dec 19, 2022 0 $0 3 Dec 21, 2022 Chief Medical Officer